P1.01-116 Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC

M. Boussageon,S. Ortiz-Cuaran,S. Chabaud,D. Pérol,V. Avrillon, B. Mastroianni,J. Fayette,F. Ghiringhelli, E. Neidhardt,A. Swalduz, V. Paulus, C. Kaderbhai, J. Fumet,P. Saintigny, M. Perol

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 3|浏览39
暂无评分
关键词
adverse event,immune checkpoint blocker,advanced non-small-cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要